www.npr.org
9 months agoHealth
White House proposes to 'march in' on patents for costly drugs
The Biden administration is proposing a framework to guide government agencies in using march-in authorities to lower the prices of taxpayer-funded drugs.
Opponents argue that march-in rights were not intended to address high drug prices. [ more ]